IC(50) Evaluation of Platinum Nanocatalysts for Cancer Treatment in Fibroblast, HeLa, and DU-145 Cell Lines

[Image: see text] Cancer is a major public health problem being one of the main causes of morbidity and mortality today. Recent advances in catalytic nanomedicine have offered new cancer therapies based on the administration of nanoparticles (NPs) of platinum (Pt) dispersed in catalytic mesoporous n...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Larraza, Pamela G., López-Goerne, Tessy M., Padilla-Godínez, Francisco J., González-López, Marco A., Hamdan-Partida, Aida, Gómez, Esteban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542800/
https://www.ncbi.nlm.nih.gov/pubmed/33043218
http://dx.doi.org/10.1021/acsomega.0c03759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542800/
https://www.ncbi.nlm.nih.gov/pubmed/33043218
http://dx.doi.org/10.1021/acsomega.0c03759

Ejemplares similares